<DOC>
	<DOCNO>NCT00907881</DOCNO>
	<brief_summary>This study assess correlation glycemic control hypoglycemia symptom score patient Type 2 diabetes , 12 week addition sulfonylurea ongoing regime oral hypoglycemic agent .</brief_summary>
	<brief_title>The OBSTACLE Hypoglycemia Study ( MK-0000-158 )</brief_title>
	<detailed_description>Patients evaluate participation study usual visit participate diabetes care clinic . Addition sulfonylurea unbiased decision participate physician base clinical need participate patient .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>Patients Type 2 Diabetes , either gender age 1875 year Patients consider addition Sulfonylurea background least one oral hypoglycemic agent , usual visit ( screen cum enrolment visit ) , per clinical situation judge participate physician Willing comply study requirement Patients type 1 Diabetes gestational Diabetes Patients currently insulin therapy receive Insulin last 6 month Patients currently Sulfonylurea therapy receive Sulfonylureas last 6 month Patients currently Meglitinides therapy receive Meglitinides last 6 month Patients initiated Sulfonylurea monotherapy Patient DPP4 inhibitor , either monotherapy combination therapy Patient , time signing informed consent , user recreational illicit drug recent history ( within last year ) drug alcohol abuse dependence . Patients would impossible complete questionnaire whatever reason , feasible form Patients already participate clinical trial clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>